Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2015 5
2016 3
2017 5
2018 8
2019 3
2020 1
2021 6
2022 4
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Neuroblastoma: an ongoing cold front for cancer immunotherapy.
Kennedy PT, Zannoupa D, Son MH, Dahal LN, Woolley JF. Kennedy PT, et al. Among authors: dahal ln. J Immunother Cancer. 2023 Nov 22;11(11):e007798. doi: 10.1136/jitc-2023-007798. J Immunother Cancer. 2023. PMID: 37993280 Free PMC article. Review.
FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms.
Simpson AP, Roghanian A, Oldham RJ, Chan HTC, Penfold CA, Kim HJ, Inzhelevskaya T, Mockridge CI, Cox KL, Bogdanov YD, James S, Tutt AL, Rycroft D, Morley P, Dahal LN, Teige I, Frendeus B, Beers SA, Cragg MS. Simpson AP, et al. Among authors: dahal ln. Cell Rep. 2022 Jul 19;40(3):111099. doi: 10.1016/j.celrep.2022.111099. Cell Rep. 2022. PMID: 35858562 Free PMC article.
Recent Progress in Interferon Therapy for Myeloid Malignancies.
Healy FM, Dahal LN, Jones JRE, Floisand Y, Woolley JF. Healy FM, et al. Among authors: dahal ln. Front Oncol. 2021 Oct 29;11:769628. doi: 10.3389/fonc.2021.769628. eCollection 2021. Front Oncol. 2021. PMID: 34778087 Free PMC article. Review.
STINGing Viral Tumors: What We Know from Head and Neck Cancers.
Saulters E, Woolley JF, Varadarajan S, Jones TM, Dahal LN. Saulters E, et al. Among authors: dahal ln. Cancer Res. 2021 Aug 1;81(15):3945-3952. doi: 10.1158/0008-5472.CAN-21-0785. Epub 2021 Apr 26. Cancer Res. 2021. PMID: 33903123 Review.
HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy.
Hussain K, Liu R, Smith RCG, Müller KTJ, Ghorbani M, Macari S, Cleary KLS, Oldham RJ, Foxall RB, James S, Booth SG, Murray T, Dahal LN, Hargreaves CE, Kemp RS, Longley J, Douglas J, Markham H, Chee SJ, Stopforth RJ, Roghanian A, Carter MJ, Ottensmeier CH, Frendéus B, Cutress RI, French RR, Glennie MJ, Strefford JC, Thirdborough SM, Beers SA, Cragg MS. Hussain K, et al. Among authors: dahal ln. J Exp Clin Cancer Res. 2022 Apr 7;41(1):131. doi: 10.1186/s13046-022-02294-5. J Exp Clin Cancer Res. 2022. PMID: 35392965 Free PMC article.
TLR-3/9 Agonists Synergize with Anti-ErbB2 mAb-Letter.
Turaj AH, Dahal LN, Beers SA, Cragg MS, Lim SH. Turaj AH, et al. Among authors: dahal ln. Cancer Res. 2017 Jun 15;77(12):3376-3378. doi: 10.1158/0008-5472.CAN-17-0412. Epub 2017 Jun 5. Cancer Res. 2017. PMID: 28584185 No abstract available.
38 results